+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jun 2023 | From USD $1799 | Published By: QY RESEARCH | Number Of Pages: 100
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Rabies Antiserum manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Rabies Antiserum market. Further, it explains the major drivers and regional dynamics of the global Rabies Antiserum market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2023. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2029.
Rabies Antiserum Segment by Type
1500IU
1000IU
400IU
Other
Rabies Antiserum Segment by Application
Category II Exposure
Category III Exposure
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Rabies Antiserum market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Rabies Antiserum, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Rabies Antiserum, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rabies Antiserum, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rabies Antiserum sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2023. Identification of the major stakeholders in the global Rabies Antiserum market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2029. Evaluation and forecast the market size for Rabies Antiserum sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Rabies Antiserum Market Size Growth Rate by Type (2017 VS 2021 VS 2029)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Rabies Antiserum Market Share by Application (2017 VS 2021 VS 2029)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Rabies Antiserum Market Size (2017-2029)
2.1.1 Global Rabies Antiserum Revenue (2017-2029)
2.1.2 Global Rabies Antiserum Sales (2017-2029)
2.2 Global Rabies Antiserum Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2029
2.2.1 Global Rabies Antiserum Sales by Regions (2017-2023)
2.2.2 Global Rabies Antiserum Revenue by Regions (2017-2023)
2.3 Global Rabies Antiserum Market Size Forecast by Region
2.3.1 Global Rabies Antiserum Sales Forecast by Region (2023-2029)
2.3.2 Global Rabies Antiserum Revenue Forecast by Region (2023-2029)
2.4 Global Top Rabies Antiserum Regions (Countries) Ranking by Market Size
2.5 Rabies Antiserum Market Dynamics
2.5.1 Rabies Antiserum Market Trends
2.5.2 Rabies Antiserum Market Drivers
2.5.3 Rabies Antiserum Market Challenges
2.5.4 Rabies Antiserum Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Rabies Antiserum Manufacturers by Sales (2017-2023)
3.1.1 Global Rabies Antiserum Sales by Manufacturers (2017-2023)
3.1.2 Global Rabies Antiserum Sales Market Share by Manufacturers (2017-2023)
3.1.3 Global 5 and 10 Largest Manufacturers by Rabies Antiserum Sales in 2021
3.2 Global Top Manufacturers Rabies Antiserum by Revenue
3.2.1 Global Rabies Antiserum Revenue by Manufacturers (2017-2023)
3.2.2 Top Rabies Antiserum Manufacturers Covered: Ranking by Revenue
3.2.3 Global Rabies Antiserum Revenue Share by Manufacturers (2017-2023)
3.2.4 Global Rabies Antiserum Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Antiserum as of 2021)
3.4 Global Rabies Antiserum Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Rabies Antiserum Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Rabies Antiserum Market
3.7 Key Manufacturers Rabies Antiserum Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Rabies Antiserum Market Size by Type
4.1 Global Rabies Antiserum Historic Market Review by Type (2017-2023)
4.1.1 Global Rabies Antiserum Sales Market Share by Type (2017-2023)
4.1.2 Global Rabies Antiserum Revenue Market Share by Type (2017-2023)
4.1.3 Rabies Antiserum Price by Type (2017-2023)
4.2 Global Rabies Antiserum Market Estimates and Forecasts by Type (2023-2029)
4.2.1 Global Rabies Antiserum Sales Forecast by Type (2023-2029)
4.2.2 Global Rabies Antiserum Revenue Forecast by Type (2023-2029)
4.2.3 Rabies Antiserum Price Forecast by Type (2023-2029)
5 Global Rabies Antiserum Market Size by Application
5.1 Global Rabies Antiserum Historic Market Review by Application (2017-2023)
5.1.1 Global Rabies Antiserum Sales Market Share by Application (2017-2023)
5.1.2 Global Rabies Antiserum Revenue Market Share by Application (2017-2023)
5.1.3 Rabies Antiserum Price by Application (2017-2023)
5.2 Global Rabies Antiserum Market Estimates and Forecasts by Application (2023-2029)
5.2.1 Global Rabies Antiserum Sales Forecast by Application (2023-2029)
5.2.2 Global Rabies Antiserum Revenue Forecast by Application (2023-2029)
5.2.3 Rabies Antiserum Price Forecast by Application (2023-2029)
6 North America
6.1 North America Rabies Antiserum Sales Breakdown by Company
6.1.1 North America Rabies Antiserum Sales by Company (2017-2023)
6.1.2 North America Rabies Antiserum Revenue by Company (2017-2023)
6.2 North America Rabies Antiserum Market Size by Type
6.2.1 North America Rabies Antiserum Sales by Type (2017-2029)
6.2.2 North America Rabies Antiserum Revenue by Type (2017-2029)
6.3 North America Rabies Antiserum Market Size by Application
6.3.1 North America Rabies Antiserum Sales by Application (2017-2029)
6.3.2 North America Rabies Antiserum Revenue by Application (2017-2029)
6.4 North America Rabies Antiserum Market Size by Country
6.4.1 North America Rabies Antiserum Sales by Country (2017-2029)
6.4.2 North America Rabies Antiserum Revenue by Country (2017-2029)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rabies Antiserum Sales Breakdown by Company
7.1.1 Europe Rabies Antiserum Sales by Company (2017-2023)
7.1.2 Europe Rabies Antiserum Revenue by Company (2017-2023)
7.2 Europe Rabies Antiserum Market Size by Type
7.2.1 Europe Rabies Antiserum Sales by Type (2017-2029)
7.2.2 Europe Rabies Antiserum Revenue by Type (2017-2029)
7.3 Europe Rabies Antiserum Market Size by Application
7.3.1 Europe Rabies Antiserum Sales by Application (2017-2029)
7.3.2 Europe Rabies Antiserum Revenue by Application (2017-2029)
7.4 Europe Rabies Antiserum Market Size by Country
7.4.1 Europe Rabies Antiserum Sales by Country (2017-2029)
7.4.2 Europe Rabies Antiserum Revenue by Country (2017-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rabies Antiserum Sales Breakdown by Company
8.1.1 Asia Pacific Rabies Antiserum Sales by Company (2017-2023)
8.1.2 Asia Pacific Rabies Antiserum Revenue by Company (2017-2023)
8.2 Asia Pacific Rabies Antiserum Market Size by Type
8.2.1 Asia Pacific Rabies Antiserum Sales by Type (2017-2029)
8.2.2 Asia Pacific Rabies Antiserum Revenue by Type (2017-2029)
8.3 Asia Pacific Rabies Antiserum Market Size by Application
8.3.1 Asia Pacific Rabies Antiserum Sales by Application (2017-2029)
8.3.2 Asia Pacific Rabies Antiserum Revenue by Application (2017-2029)
8.4 Asia Pacific Rabies Antiserum Market Size by Region
8.4.1 Asia Pacific Rabies Antiserum Sales by Region
8.4.2 Asia Pacific Rabies Antiserum Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Rabies Antiserum Sales Breakdown by Company
9.1.1 Latin America Rabies Antiserum Sales by Company (2017-2023)
9.1.2 Latin America Rabies Antiserum Revenue by Company (2017-2023)
9.2 Latin America Rabies Antiserum Market Size by Type
9.2.1 Latin America Rabies Antiserum Sales by Type (2017-2029)
9.2.2 Latin America Rabies Antiserum Revenue by Type (2017-2029)
9.3 Latin America Rabies Antiserum Market Size by Application
9.3.1 Latin America Rabies Antiserum Sales by Application (2017-2029)
9.3.2 Latin America Rabies Antiserum Revenue by Application (2017-2029)
9.4 Latin America Rabies Antiserum Market Size by Country
9.4.1 Latin America Rabies Antiserum Sales by Country (2017-2029)
9.4.2 Latin America Rabies Antiserum Revenue by Country (2017-2029)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rabies Antiserum Sales Breakdown by Company
10.1.1 Middle East and Africa Rabies Antiserum Sales by Company (2017-2023)
10.1.2 Middle East and Africa Rabies Antiserum Revenue by Company (2017-2023)
10.2 Middle East and Africa Rabies Antiserum Market Size by Type
10.2.1 Middle East and Africa Rabies Antiserum Sales by Type (2017-2029)
10.2.2 Middle East and Africa Rabies Antiserum Revenue by Type (2017-2029)
10.3 Middle East and Africa Rabies Antiserum Market Size by Application
10.3.1 Middle East and Africa Rabies Antiserum Sales by Application (2017-2029)
10.3.2 Middle East and Africa Rabies Antiserum Revenue by Application (2017-2029)
10.4 Middle East and Africa Rabies Antiserum Market Size by Country
10.4.1 Middle East and Africa Rabies Antiserum Sales by Country (2017-2029)
10.4.2 Middle East and Africa Rabies Antiserum Revenue by Country (2017-2029)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Serum China
11.1.1 Serum China Corporation Information
11.1.2 Serum China Overview
11.1.3 Serum China Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.1.4 Serum China Rabies Antiserum Products and Services
11.1.5 Serum China Rabies Antiserum SWOT Analysis
11.1.6 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Corporation Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.2.4 Lanzhou Institute of Biological Products Rabies Antiserum Products and Services
11.2.5 Lanzhou Institute of Biological Products Rabies Antiserum SWOT Analysis
11.2.6 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Corporation Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.3.4 Wuhan Institute of Biological Products Rabies Antiserum Products and Services
11.3.5 Wuhan Institute of Biological Products Rabies Antiserum SWOT Analysis
11.3.6 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Corporation Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.4.4 Premium Serums Rabies Antiserum Products and Services
11.4.5 Premium Serums Rabies Antiserum SWOT Analysis
11.4.6 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.5.4 Haffkine Bio-Pharmaceutical Rabies Antiserum Products and Services
11.5.5 Haffkine Bio-Pharmaceutical Rabies Antiserum SWOT Analysis
11.5.6 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Corporation Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Rabies Antiserum Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2023)
11.6.4 Bharat Serums Rabies Antiserum Products and Services
11.6.5 Bharat Serums Rabies Antiserum SWOT Analysis
11.6.6 Bharat Serums Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Rabies Antiserum Value Chain Analysis
12.2 Rabies Antiserum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Antiserum Production Mode & Process
12.4 Rabies Antiserum Sales and Marketing
12.4.1 Rabies Antiserum Sales Channels
12.4.2 Rabies Antiserum Distributors
12.5 Rabies Antiserum Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Rabies Antiserum Market Size Growth Rate by Type, 2017 VS 2021 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Rabies Antiserum Market Size Growth Rate by Application, 2017 VS 2021 VS 2029 (US$ Million)
Table 7. Global Rabies Antiserum Market Size (US$ Million) by Region: 2017 VS 2021 VS 2029
Table 8. Global Rabies Antiserum Sales by Region (2017-2023) & (Kiloton)
Table 9. Global Rabies Antiserum Sales Market Share by Region (2017-2023)
Table 10. Global Rabies Antiserum Revenue by Region (2017-2023) & (US$ Million)
Table 11. Global Rabies Antiserum Revenue Market Share by Region (2017-2023)
Table 12. Global Rabies Antiserum Sales Forecast by Region (2023-2029) & (Kiloton)
Table 13. Global Rabies Antiserum Sales Market Share Forecast by Region (2023-2029)
Table 14. Global Rabies Antiserum Revenue Forecast by Region (2023-2029) & (US$ Million)
Table 15. Global Rabies Antiserum Revenue Market Share Forecast by Region (2023-2029)
Table 16. Top Rabies Antiserum Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Rabies Antiserum Market Trends
Table 18. Rabies Antiserum Market Drivers
Table 19. Rabies Antiserum Market Challenges
Table 20. Rabies Antiserum Market Restraints
Table 21. Global Rabies Antiserum Sales by Manufacturers (2017-2023) & (Kiloton)
Table 22. Global Rabies Antiserum Sales Share by Manufacturers (2017-2023)
Table 23. Global Rabies Antiserum Revenue by Manufacturers (2017-2023) & (US$ Million)
Table 24. Ranking of Global Top Rabies Antiserum Manufacturers by Revenue (US$ Million) in 2021
Table 25. Rabies Antiserum Revenue Share by Manufacturers (2017-2023)
Table 26. Global Rabies Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Antiserum as of 2021)
Table 28. Key Manufacturers Rabies Antiserum Average Selling Price (ASP) & (2017-2023) & (US$/Ton)
Table 29. Key Manufacturers Rabies Antiserum Plants/Factories Distribution
Table 30. Key Manufacturers Rabies Antiserum Area Served
Table 31. Date of Key Manufacturers Enter into Rabies Antiserum Market
Table 32. Key Manufacturers Rabies Antiserum Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Rabies Antiserum Sales (Kiloton) by Type (2017-2023)
Table 35. Global Rabies Antiserum Sales Share by Type (2017-2023)
Table 36. Global Rabies Antiserum Revenue (US$ Million) Market Share by Type (2017-2023)
Table 37. Global Rabies Antiserum Price (Kiloton) by Type (2017-2023)
Table 38. Global Rabies Antiserum Sales (Kiloton) by Type (2023-2029)
Table 39. Global Rabies Antiserum Sales Share by Type (2023-2029)
Table 40. Global Rabies Antiserum Revenue (US$ Million) Market Share by Type (2023-2029)
Table 41. Global Rabies Antiserum Revenue Share by Type (2023-2029)
Table 42. Global Rabies Antiserum Price (Kiloton) by Type (2023-2029)
Table 43. Global Rabies Antiserum Sales (Kiloton) by Application (2017-2023)
Table 44. Global Rabies Antiserum Sales Share by Application (2017-2023)
Table 45. Global Rabies Antiserum Revenue (US$ Million) Market Share by Application (2017-2023)
Table 46. Global Rabies Antiserum Price (Kiloton) by Application (2017-2023)
Table 47. Global Rabies Antiserum Sales (Kiloton) by Application (2023-2029)
Table 48. Global Rabies Antiserum Sales Share by Application (2023-2029)
Table 49. Global Rabies Antiserum Revenue (US$ Million) Market Share by Application (2023-2029)
Table 50. Global Rabies Antiserum Revenue Share by Application (2023-2029)
Table 51. Global Rabies Antiserum Price (Kiloton) by Application (2023-2029)
Table 52. North America Rabies Antiserum Sales by Company (2017-2023) & (Kiloton)
Table 53. North America Rabies Antiserum Sales Market Share by Company (2017-2023)
Table 54. North America Rabies Antiserum Revenue by Company (2017-2023) & (US$ Million)
Table 55. North America Rabies Antiserum Revenue Market Share by Company (2017-2023)
Table 56. North America Rabies Antiserum Sales by Type (2017-2023) & (Kiloton)
Table 57. North America Rabies Antiserum Sales by Type (2023-2029) & (Kiloton)
Table 58. North America Rabies Antiserum Revenue by Type (2017-2023) & (US$ Million)
Table 59. North America Rabies Antiserum Revenue by Type (2023-2029) & (US$ Million)
Table 60. North America Rabies Antiserum Sales by Application (2017-2023) & (Kiloton)
Table 61. North America Rabies Antiserum Sales by Application (2023-2029) & (Kiloton)
Table 62. North America Rabies Antiserum Revenue by Application (2017-2023) & (US$ Million)
Table 63. North America Rabies Antiserum Revenue by Application (2023-2029) & (US$ Million)
Table 64. North America Rabies Antiserum Sales by Country (2017-2023) & (Kiloton)
Table 65. North America Rabies Antiserum Sales by Country (2023-2029) & (Kiloton)
Table 66. North America Rabies Antiserum Revenue by Country (2017-2023) & (US$ Million)
Table 67. North America Rabies Antiserum Revenue by Country (2023-2029) & (US$ Million)
Table 68. Europe Rabies Antiserum Sales by Company (2017-2023) & (Kiloton)
Table 69. Europe Rabies Antiserum Sales Market Share by Company (2017-2023)
Table 70. Europe Rabies Antiserum Revenue by Company (2017-2023) & (US$ Million)
Table 71. Europe Rabies Antiserum Revenue Market Share by Company (2017-2023)
Table 72. Europe Rabies Antiserum Sales by Type (2017-2023) & (Kiloton)
Table 73. Europe Rabies Antiserum Sales by Type (2023-2029) & (Kiloton)
Table 74. Europe Rabies Antiserum Revenue by Type (2017-2023) & (US$ Million)
Table 75. Europe Rabies Antiserum Revenue by Type (2023-2029) & (US$ Million)
Table 76. Europe Rabies Antiserum Sales by Application (2017-2023) & (Kiloton)
Table 77. Europe Rabies Antiserum Sales by Application (2023-2029) & (Kiloton)
Table 78. Europe Rabies Antiserum Revenue by Application (2017-2023) & (US$ Million)
Table 79. Europe Rabies Antiserum Revenue by Application (2023-2029) & (US$ Million)
Table 80. Europe Rabies Antiserum Sales by Country (2017-2023) & (Kiloton)
Table 81. Europe Rabies Antiserum Sales by Country (2023-2029) & (Kiloton)
Table 82. Europe Rabies Antiserum Revenue by Country (2017-2023) & (US$ Million)
Table 83. Europe Rabies Antiserum Revenue by Country (2023-2029) & (US$ Million)
Table 84. Asia Pacific Rabies Antiserum Sales by Company (2017-2023) & (Kiloton)
Table 85. Asia Pacific Rabies Antiserum Sales Market Share by Company (2017-2023)
Table 86. Asia Pacific Rabies Antiserum Revenue by Company (2017-2023) & (US$ Million)
Table 87. Asia Pacific Rabies Antiserum Revenue Market Share by Company (2017-2023)
Table 88. Asia Pacific Rabies Antiserum Sales by Type (2017-2023) & (Kiloton)
Table 89. Asia Pacific Rabies Antiserum Sales by Type (2023-2029) & (Kiloton)
Table 90. Asia Pacific Rabies Antiserum Revenue by Type (2017-2023) & (US$ Million)
Table 91. Asia Pacific Rabies Antiserum Revenue by Type (2023-2029) & (US$ Million)
Table 92. Asia Pacific Rabies Antiserum Sales by Application (2017-2023) & (Kiloton)
Table 93. Asia Pacific Rabies Antiserum Sales by Application (2023-2029) & (Kiloton)
Table 94. Asia Pacific Rabies Antiserum Revenue by Application (2017-2023) & (US$ Million)
Table 95. Asia Pacific Rabies Antiserum Revenue by Application (2023-2029) & (US$ Million)
Table 96. Asia Pacific Rabies Antiserum Sales by Region (2017-2023) & (Kiloton)
Table 97. Asia Pacific Rabies Antiserum Sales by Region (2023-2029) & (Kiloton)
Table 98. Asia Pacific Rabies Antiserum Revenue by Region (2017-2023) & (US$ Million)
Table 99. Asia Pacific Rabies Antiserum Revenue by Region (2023-2029) & (US$ Million)
Table 100. Latin America Rabies Antiserum Sales by Company (2017-2023) & (Kiloton)
Table 101. Latin America Rabies Antiserum Sales Market Share by Company (2017-2023)
Table 102. Latin America Rabies Antiserum Revenue by Company (2017-2023) & (US$ Million)
Table 103. Latin America Rabies Antiserum Revenue Market Share by Company (2017-2023)
Table 104. Latin America Rabies Antiserum Sales by Type (2017-2023) & (Kiloton)
Table 105. Latin America Rabies Antiserum Sales by Type (2023-2029) & (Kiloton)
Table 106. Latin America Rabies Antiserum Revenue by Type (2017-2023) & (US$ Million)
Table 107. Latin America Rabies Antiserum Revenue by Type (2023-2029) & (US$ Million)
Table 108. Latin America Rabies Antiserum Sales by Application (2017-2023) & (Kiloton)
Table 109. Latin America Rabies Antiserum Sales by Application (2023-2029) & (Kiloton)
Table 110. Latin America Rabies Antiserum Revenue by Application (2017-2023) & (US$ Million)
Table 111. Latin America Rabies Antiserum Revenue by Application (2023-2029) & (US$ Million)
Table 112. Latin America Rabies Antiserum Sales by Country (2017-2023) & (Kiloton)
Table 113. Latin America Rabies Antiserum Sales by Country (2023-2029) & (Kiloton)
Table 114. Latin America Rabies Antiserum Revenue by Country (2017-2023) & (US$ Million)
Table 115. Latin America Rabies Antiserum Revenue by Country (2023-2029) & (US$ Million)
Table 116. Middle East and Africa Rabies Antiserum Sales by Company (2017-2023) & (Kiloton)
Table 117. Middle East and Africa Rabies Antiserum Sales Market Share by Company (2017-2023)
Table 118. Middle East and Africa Rabies Antiserum Revenue by Company (2017-2023) & (US$ Million)
Table 119. Middle East and Africa Rabies Antiserum Revenue Market Share by Company (2017-2023)
Table 120. Middle East and Africa Rabies Antiserum Sales by Type (2017-2023) & (Kiloton)
Table 121. Middle East and Africa Rabies Antiserum Sales by Type (2023-2029) & (Kiloton)
Table 122. Middle East and Africa Rabies Antiserum Revenue by Type (2017-2023) & (US$ Million)
Table 123. Middle East and Africa Rabies Antiserum Revenue by Type (2023-2029) & (US$ Million)
Table 124. Middle East and Africa Rabies Antiserum Sales by Application (2017-2023) & (Kiloton)
Table 125. Middle East and Africa Rabies Antiserum Sales by Application (2023-2029) & (Kiloton)
Table 126. Middle East and Africa Rabies Antiserum Revenue by Application (2017-2023) & (US$ Million)
Table 127. Middle East and Africa Rabies Antiserum Revenue by Application (2023-2029) & (US$ Million)
Table 128. Middle East and Africa Rabies Antiserum Sales by Country (2017-2023) & (Kiloton)
Table 129. Middle East and Africa Rabies Antiserum Sales by Country (2023-2029) & (Kiloton)
Table 130. Middle East and Africa Rabies Antiserum Revenue by Country (2017-2023) & (US$ Million)
Table 131. Middle East and Africa Rabies Antiserum Revenue by Country (2023-2029) & (US$ Million)
Table 132. Serum China Corporation Information
Table 133. Serum China Description and Overview
Table 134. Serum China Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 135. Serum China Rabies Antiserum Product and Services
Table 136. Serum China Rabies Antiserum SWOT Analysis
Table 137. Serum China Recent Developments
Table 138. Lanzhou Institute of Biological Products Corporation Information
Table 139. Lanzhou Institute of Biological Products Description and Overview
Table 140. Lanzhou Institute of Biological Products Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 141. Lanzhou Institute of Biological Products Rabies Antiserum Product and Services
Table 142. Lanzhou Institute of Biological Products Rabies Antiserum SWOT Analysis
Table 143. Lanzhou Institute of Biological Products Recent Developments
Table 144. Wuhan Institute of Biological Products Corporation Information
Table 145. Wuhan Institute of Biological Products Description and Overview
Table 146. Wuhan Institute of Biological Products Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 147. Wuhan Institute of Biological Products Rabies Antiserum Product and Services
Table 148. Wuhan Institute of Biological Products Rabies Antiserum SWOT Analysis
Table 149. Wuhan Institute of Biological Products Recent Developments
Table 150. Premium Serums Corporation Information
Table 151. Premium Serums Description and Overview
Table 152. Premium Serums Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 153. Premium Serums Rabies Antiserum Product and Services
Table 154. Premium Serums Rabies Antiserum SWOT Analysis
Table 155. Premium Serums Recent Developments
Table 156. Haffkine Bio-Pharmaceutical Corporation Information
Table 157. Haffkine Bio-Pharmaceutical Description and Overview
Table 158. Haffkine Bio-Pharmaceutical Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 159. Haffkine Bio-Pharmaceutical Rabies Antiserum Product and Services
Table 160. Haffkine Bio-Pharmaceutical Rabies Antiserum SWOT Analysis
Table 161. Haffkine Bio-Pharmaceutical Recent Developments
Table 162. Bharat Serums Corporation Information
Table 163. Bharat Serums Description and Overview
Table 164. Bharat Serums Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2023)
Table 165. Bharat Serums Rabies Antiserum Product and Services
Table 166. Bharat Serums Rabies Antiserum SWOT Analysis
Table 167. Bharat Serums Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Rabies Antiserum Distributors List
Table 171. Rabies Antiserum Customers List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Antiserum Product Picture
Figure 2. Global Rabies Antiserum Sales Market Share by Type in 2021 & 2029
Figure 3. 1500IU Product Picture
Figure 4. 1000IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Rabies Antiserum Sales Market Share by Application in 2021 & 2029
Figure 8. Category II Exposure Use Case
Figure 9. Category III Exposure Use Case
Figure 10. Rabies Antiserum Report Years Considered
Figure 11. Global Rabies Antiserum Revenue, (US$ Million), 2017 VS 2021 VS 2029
Figure 12. Global Rabies Antiserum Market Size 2017-2029 (US$ Million)
Figure 13. Global Rabies Antiserum Sales (2017-2023) & (Kiloton)
Figure 14. Global Rabies Antiserum Market Size Market Share by Region: 2021 VS 2029
Figure 15. Global Rabies Antiserum Sales Market Share by Region (2017-2023)
Figure 16. Global Rabies Antiserum Sales Market Share by Region in 2021
Figure 17. Global Rabies Antiserum Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Rabies Antiserum Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Antiserum Sales in 2021
Figure 20. Rabies Antiserum Revenue Share by Manufacturers in 2021
Figure 21. Rabies Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Rabies Antiserum Revenue Share by Type (2017-2023)
Figure 23. Global Rabies Antiserum Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Rabies Antiserum Revenue Share by Application (2017-2023)
Figure 25. Global Rabies Antiserum Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Rabies Antiserum Sales Market Share by Type (2017-2029)
Figure 27. North America Rabies Antiserum Revenue Market Share by Type (2017-2029)
Figure 28. North America Rabies Antiserum Sales Market Share by Application (2017-2029)
Figure 29. North America Rabies Antiserum Revenue Market Share by Application (2017-2029)
Figure 30. North America Rabies Antiserum Sales Share by Country (2017-2029)
Figure 31. North America Rabies Antiserum Revenue Share by Country (2017-2029)
Figure 32. United States Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 33. Canada Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 34. Europe Rabies Antiserum Sales Market Share by Type (2017-2029)
Figure 35. Europe Rabies Antiserum Revenue Market Share by Type (2017-2029)
Figure 36. Europe Rabies Antiserum Sales Market Share by Application (2017-2029)
Figure 37. Europe Rabies Antiserum Revenue Market Share by Application (2017-2029)
Figure 38. Europe Rabies Antiserum Sales Share by Country (2017-2029)
Figure 39. Europe Rabies Antiserum Revenue Share by Country (2017-2029)
Figure 40. Germany Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 41. France Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 42. U.K. Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 43. Italy Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 44. Russia Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 45. Asia Pacific Rabies Antiserum Sales Market Share by Type (2017-2029)
Figure 46. Asia Pacific Rabies Antiserum Revenue Market Share by Type (2017-2029)
Figure 47. Asia Pacific Rabies Antiserum Sales Market Share by Application (2017-2029)
Figure 48. Asia Pacific Rabies Antiserum Revenue Market Share by Application (2017-2029)
Figure 49. Asia Pacific Rabies Antiserum Sales Share by Region (2017-2029)
Figure 50. Asia Pacific Rabies Antiserum Revenue Share by Region (2017-2029)
Figure 51. China Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 52. Japan Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 53. South Korea Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 54. India Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 55. Australia Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 56. China Taiwan Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 57. Indonesia Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 58. Thailand Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 59. Malaysia Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 60. Latin America Rabies Antiserum Sales Market Share by Type (2017-2029)
Figure 61. Latin America Rabies Antiserum Revenue Market Share by Type (2017-2029)
Figure 62. Latin America Rabies Antiserum Sales Market Share by Application (2017-2029)
Figure 63. Latin America Rabies Antiserum Revenue Market Share by Application (2017-2029)
Figure 64. Latin America Rabies Antiserum Sales Share by Country (2017-2029)
Figure 65. Latin America Rabies Antiserum Revenue Share by Country (2017-2029)
Figure 66. Mexico Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 67. Brazil Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 68. Argentina Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 69. Middle East and Africa Rabies Antiserum Sales Market Share by Type (2017-2029)
Figure 70. Middle East and Africa Rabies Antiserum Revenue Market Share by Type (2017-2029)
Figure 71. Middle East and Africa Rabies Antiserum Sales Market Share by Application (2017-2029)
Figure 72. Middle East and Africa Rabies Antiserum Revenue Market Share by Application (2017-2029)
Figure 73. Middle East and Africa Rabies Antiserum Sales Share by Country (2017-2029)
Figure 74. Middle East and Africa Rabies Antiserum Revenue Share by Country (2017-2029)
Figure 75. Turkey Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 76. Saudi Arabia Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 77. UAE Rabies Antiserum Revenue (2017-2029) & (US$ Million)
Figure 78. Rabies Antiserum Value Chain
Figure 79. Rabies Antiserum Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
